Key points are not available for this paper at this time.
We report the 5-year study closeout results for the ROBUST I trial evaluating the safety and efficacy of the Optilume drug-coated balloon (DCB) for men with short, recurrent bulbar urethral strictures.
DeLong et al. (Fri,) studied this question.